Recent News: Cancer Immunotherapy & Vaccines

and/or

24 News Items found

In the Lab

MSK Scientists Fine-Tune CAR T Cells to Improve Their Performance

The updated versions can survive longer in the body while still packing a punch against cancer.

Illustration of mechanical arms altering a cell

In the Lab

The Immune System Can Fight Cancer. So Why Doesn’t It?

New research from scientists at the Sloan Kettering Institute helps explain how growing tumors escape our immune defenses.

a cabinet full of yellow rubber duckies and one blue one

In the News

Former MSK Immunologist James Allison Wins Nobel Prize in Medicine

Dr. Allison is being honored for discovering how to take the brakes off cancer-fighting immune cells.

James Allison

Finding

Discovery of Unusual Cell Type Could Help Guide Immunotherapy

A newly identified group of immunosuppressive cells could provide insight into the effects of immunotherapy drugs.

Scanning electron micrograph (SEM) of T lymphocyte cells (blue) attached to a red cancer cell.

In the Clinic

Chemotherapy-Immunotherapy Combination Aims to Knock Out Melanoma with a One-Two Punch

A new approach for treating melanoma combines the immunotherapy drug ipilimumab with chemotherapy that treats only the area affected by cancer.

Jedd Wolchok and Charlotte Ariyan in the lab

In the Clinic

Longest-Running CAR T Trial Shows Which Patients Benefit Most, Have Fewest Side Effects

For adults with chemotherapy-resistant leukemia, CAR T cell therapy can be a lifesaving treatment option. New results suggest how to make it safer.

Medical oncologist Jae Park

In the Lab

New Hope for Repairing a Damaged or Aging Immune System

Scientists have uncovered a molecule that, in mice, can promote the regeneration of the thymus, where T cells develop.

Three-dimensional reconstruction of the blood vessels in a mouse thymus using light-sheet fluorescent microscopy

In the Lab

Why Immune Cells Sometimes Fail to Fight Cancer (and What to Do about It)

By looking at how DNA is packaged in cells, scientists are teasing apart a long-standing conundrum about the immune response to cancer.

Scientists at the Sloan Kettering Institute are learning why some immune cells are stubbornly hard to revive with immunotherapy.

Feature

T Is for T Cell: The Science Behind Immunotherapy

By deciphering the biology of T cells, MSK scientists gave immunotherapy a boost.

T cells on the loose.